Inflammatory stress and sarcomagenesis: a vicious interplay
1multimmune GmbH c/o Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Straße 22, 81675, Munich, Germany, raj10062@web.de.
Cell Stress & Chaperones
|September 19, 2013
Summary
Chronic inflammation drives sarcoma development by activating key pathways like HIF-1 and NF-κB. New targeted therapies aim to disrupt this link, offering hope for better sarcoma treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Chronic inflammation is a known hallmark of cancer, yet its specific role in sarcomagenesis remains understudied.
- Sarcomas, rare mesenchymal tumors, disproportionately affect children and are linked to poor prognoses, necessitating novel therapeutic strategies.
Purpose of the Study:
- To provide an overview of the molecular pathways linking inflammation and sarcomagenesis.
- To review preclinical and clinical evidence for targeted therapies addressing the inflammation-sarcoma connection.
Main Methods:
- Review of preclinical data on molecular pathways involved in inflammation-driven sarcomagenesis.
- Analysis of clinical evidence for targeted therapies in sarcoma treatment.
- Focus on key transcription factors: HIF-1, NF-κB, and STAT-3.
Main Results:
- Inflammation activates critical transcription factors (HIF-1, NF-κB, STAT-3) in a complex network promoting sarcomagenesis.
- Emerging targeted therapies show promise in interrupting the inflammation-sarcomagenesis cycle.
- Identification of new therapeutic targets for sarcoma treatment.
Conclusions:
- Inflammation plays a significant, previously overlooked role in the development of sarcomas.
- Targeting the interplay between inflammation and sarcomagenesis represents a promising therapeutic avenue for sarcoma patients.
Related Concept Videos
01:19Psychoneuroimmunology: Diabetes and Cancer
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...